Is GAD-7 only for generalized anxiety disorder?

No. Although GAD-7 was developed and validated specifically for generalized anxiety disorder (GAD), Kroenke and colleagues demonstrated in 2007 that it also serves as a primary-care screening tool for social anxiety disorder, panic disorder, and PTSD. It shows a sensitivity of 66% to 74% at a cutoff score of 10. A positive GAD-7 result in a patient who does not meet GAD criteria during a clinical interview is not a false positive; instead, it indicates the possibility of one of the other three conditions.

How does GAD-7 differ from GAD-2?

GAD-2 consists of the first two items of the GAD-7 - anxious arousal and uncontrolled worry - and serves as an ultra-brief entry screen. A GAD-2 score of 3 or higher prompts escalation to the full GAD-7 in primary care. While sensitivity is comparable between the two, GAD-7 demonstrates substantially higher specificity. This difference is why clinicians escalate care after a positive GAD-2 instead of treating GAD-2 as a definitive diagnosis.

What is the GAD-7 cutoff for clinical concern?

The most clinically meaningful cutoff is 10. At this level, the GAD-7 achieves 89% sensitivity and 82% specificity for generalized anxiety disorder (GAD) compared to structured psychiatric interviews in the validation cohort (Spitzer 2006). Most anxiety-screening programs use 10 to trigger further evaluation.

Can a nurse administer GAD-7 independently?

Yes. GAD-7 is a self-report instrument and is routinely administered by nursing staff in admission, primary-care, and ED settings. The score and the documentation belong to the nurse who administered it; the diagnostic interpretation belongs to a clinician licensed to make an anxiety-disorder diagnosis. Administering and scoring GAD-7 is within nursing scope; diagnosing GAD or any other anxiety disorder from the score is not.

Should GAD-7 always pair with PHQ-9?

In any patient with mood symptoms alongside anxiety symptoms, yes. Depression and anxiety co-occur often enough that Kroenke and colleagues developed the PHQ-4 in 2009 specifically to catch both with one ultra-brief instrument (PHQ-2 + GAD-2). When low mood, anhedonia, sleep changes, or appetite changes are endorsed alongside anxiety, PHQ-9 should follow GAD-7 in the same encounter.

How often should GAD-7 be repeated?

In primary care, every 4 to 6 weeks is a common interval for monitoring response to treatment. In inpatient settings, repeat administration is uncommon during a short stay unless symptoms shift; the score reflects the 2-week recall window and a repeat the next day rarely produces clinically actionable change. Document the rationale when the score is repeated so the next reader understands why.

By Miranda, Nursing Student (BSN candidate)

This guide is currently pending review by a licensed clinical nurse.

Last updated: April 26, 2026

How to Score and Document a GAD-7 (Nursing Guide)

Quick Reference

The GAD-7 is a 7-item generalized anxiety screen, scored from 0 to 3 for each item over the past 2 weeks. Total scores range from 0 to 21 and correspond to four severity bands. This instrument also screens for social anxiety disorder, panic disorder, and PTSD, demonstrating strong primary-care screening characteristics.

0-4 minimal anxiety; 5-9 mild; 10-14 moderate; 15-21 severe
Each item scored 0 (not at all), 1 (several days), 2 (more than half the days), 3 (nearly every day), recall window 2 weeks
Cutoff 10 is the most clinically meaningful threshold (89% sensitivity, 82% specificity for GAD)
Also screens social anxiety disorder, panic disorder, and PTSD with sensitivity 66-74% at cutoff 10 (Kroenke 2007)
GAD-2 (items 1 and 2) is the typical primary-care entry screen; a GAD-2 of 3 or higher escalates to full GAD-7
GAD-7 is a screen, not a diagnosis; a positive score prompts a clinical interview, not a chart label
Validated in adult primary-care populations; pediatric anxiety screening uses different instruments (SCARED, MASC)
A complete chart entry includes the total score, the 7 component scores, the functional-impairment response, and the plan.

Your med-surg admission features a fictional 27-year-old whose chest pain resolved in the ED. The GAD-7 administered on every admission returns a score of 16, with all seven items positive. Cardiology is still ruling out ACS, but the screening protocol indicates she meets the severe band on a validated anxiety scale. I encountered a similar scenario on my last clinical rotation. The framework that clarified this for me includes the 2-week recall, the four severity bands, and treating the score as a screen rather than a diagnosis.

Video coming soon — subscribe to be notified when new episodes drop.

Why This Matters

Regulatory bodies: U.S. Preventive Services Task Force (USPSTF), American Academy of Family Physicians (AAFP), American Psychiatric Association (APA)

GAD-7 was developed by Spitzer, Kroenke, Williams, and Löwe in 2006 as a brief screen for generalized anxiety disorder, validated in 2,740 patients across 15 U.S. primary-care clinics. At a cutoff of 10, the instrument achieved 89% sensitivity and 82% specificity for GAD against structured psychiatric interviews, demonstrating strong factor-analytic separation from depression symptoms in the same patients. In 2007, Kroenke and colleagues conducted a primary-care prevalence study showing that GAD-7 also effectively screens for social anxiety disorder, panic disorder, and PTSD, with sensitivity ranging from 66% to 74% at the same cutoff of 10. One screening instrument covers four anxiety-spectrum conditions. AAFP primary-care guidance recommends GAD-7 as the first-line anxiety screen due to this breadth, and the Locke 2015 American Family Physician primary-care review of GAD and panic disorder names GAD-7 alongside the Severity Measure for Panic Disorder as the standard primary-care assessment combination. The 2023 USPSTF Recommendation Statement on Screening for Anxiety Disorders in Adults gives adult anxiety screening a Grade B (with an Insufficient I statement for adults aged 65 and older) and reports in the supporting evidence review that the GAD-7 performed as well or better than the GAD-2 at a cutoff of 10. From a documentation standpoint, GAD-7 is less YMYL-loaded than PHQ-9 because it lacks an equivalent of item 9, but the same chart-audit pattern applies. The total score alone is insufficient; the component scores reveal the differential between primary anxiety and the secondary conditions that GAD-7 also detects. The screen does not provide a diagnosis. The most useful clinical lens is comorbidity. Depression and anxiety frequently co-occur, prompting Kroenke and colleagues to develop the PHQ-4 in 2009, an ultra-brief 4-item screen that combines the PHQ-2 and the GAD-2 into a single instrument. When administering GAD-7 alone to a patient with mood symptoms, there is a high risk of missing comorbid depression; conversely, PHQ-9 alone overlooks the anxiety dimension. The two often coexist for a reason.

A brief measure for assessing generalized anxiety disorder: the GAD-7 — Spitzer RL, Kroenke K, Williams JBW, Löwe B. Arch Intern Med. 2006;166(10):1092-1097 (2006)
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection — Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Ann Intern Med. 2007;146(5):317-325 (2007)
Generalized Anxiety Disorder and Panic Disorder in Adults — Locke AB, Kirst N, Shultz CG. Am Fam Physician. 2015;91(9):617-624 (2015)
An ultra-brief screening scale for anxiety and depression: the PHQ-4 — Kroenke K, Spitzer RL, Williams JBW, Löwe B. Psychosomatics. 2009;50(6):613-621 (2009)
Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement — US Preventive Services Task Force. JAMA. 2023;329(24):2163-2170. doi:10.1001/jama.2023.9301 (2023)
988 Suicide and Crisis Lifeline (federally designated) — SAMHSA / Vibrant Emotional Health, 988 Suicide and Crisis Lifeline (active 2024, anxiety with comorbid suicidal ideation referral resource) (2024)

What the GAD-7 Measures and Where It Is Used

GAD-7 is a 7-item self-report anxiety screen that aligns with the DSM symptoms of generalized anxiety disorder. Patients rate how often each of the seven listed problems bothered them over the past 2 weeks on a 0-to-3 scale: 0 means not at all, 1 means several days, 2 means more than half the days, and 3 means nearly every day. Total scores range from 0 to 21 and correspond to four severity bands. Spitzer and colleagues validated the instrument in 2006 with 2,740 patients across 15 U.S. primary-care clinics; at a cutoff of 10, the instrument achieved 89% sensitivity and 82% specificity for GAD compared to structured psychiatric interviews. Factor analysis confirmed that anxiety and depression symptoms loaded on separate dimensions, even though they frequently co-occurred in the same patients. This finding supports treating GAD-7 as a measure of anxiety severity rather than a generic distress score. GAD-7 appears in various settings: primary care, ED behavioral-health holds, perinatal screening, oncology and chronic-illness clinics, inpatient psych admissions, and med-surg admissions where the unit protocol screens every patient. It is validated for adults. Pediatric anxiety screening uses different instruments (SCARED, MASC, the Spence Children's Anxiety Scale) because symptom presentations differ. GAD-7 serves as a screen, not a diagnosis. A positive score prompts a clinical interview and, in inpatient settings, a documented plan, rather than a labeled diagnosis on the chart.

The 7 Items, Walked Top Down

The GAD-7 assesses the symptom domains of generalized anxiety disorder. Each item receives a rating from 0 to 3 based on the past 2 weeks.

Item 1 - Feeling Nervous, Anxious, or On Edge

This cardinal item serves as the first half of the GAD-2 entry screen. It captures the patient's subjective experience of anxious arousal. Patients often endorse this item heavily due to their reason for admission (preoperative day, ED workup, recent diagnosis). The score reflects their experience, but the differential diagnosis emerges during the clinical interview that follows.

Item 2 - Not Being Able to Stop or Control Worrying

The control dimension of worry. The second item of the GAD-2. This item is what distinguishes anxiety from worry that the patient can set down; a high score here points more strongly toward GAD than items capturing situational anxiety alone.

Item 3 - Worrying Too Much About Different Things

This item reflects the breadth dimension of worry. Generalized anxiety, by DSM definition, involves worry across multiple domains. A patient who scores high on item 3 indicates that their worry is not focused on a single concern but spreads across several areas.

Item 4 - Trouble Relaxing

This item highlights the somatic and behavioral consequences of sustained anxiety. It often co-elevates with items 5 and 6 in patients with high baseline arousal; this cluster frequently presents at the bedside.

Item 5 - Being So Restless That It Is Hard to Sit Still

The motor restlessness item. Observable to staff and family. If the patient's self-report on item 5 does not match what the unit team has observed (high self-rating, calm at the bedside, or vice versa), the disconnect itself is a useful signal worth a follow-up question in the clinical interview.

Item 6 - Becoming Easily Annoyed or Irritable

The irritability dimension. Frequently elevated in anxiety even when the patient does not name irritability as the chief complaint. Worth flagging for collateral history (spouse, family) because patients often underreport their own irritability while family members notice it clearly.

Item 7 - Feeling Afraid as if Something Awful Might Happen

This item captures the catastrophic-thinking dimension. It reflects the cognitive pattern of anticipated harm characteristic of GAD and panic disorder. A high score on item 7, in isolation with the rest of the GAD-7 sub-threshold, may indicate panic disorder rather than GAD.

Functional Impairment Item (Sometimes Called Item 8)

How difficult have these problems made it for you to work, take care of things at home, or get along with others? This question is identical to the PHQ-9 functional-impairment question. It is asked alongside the score but does not contribute to the total. Document the response as a separate field with four options (not difficult at all, somewhat difficult, very difficult, extremely difficult), which is required for documentation completeness.

Scoring and Severity Bands

Scoring involves straightforward arithmetic: sum the 0-to-3 scores across all 7 items to obtain a total ranging from 0 to 21. The severity bands are as follows: 0 to 4 indicates minimal anxiety, 5 to 9 indicates mild anxiety, 10 to 14 indicates moderate anxiety, and 15 to 21 indicates severe anxiety. The cutoff of 10 serves as the most clinically meaningful threshold, which most anxiety-screening programs use to trigger further evaluation. Although the functional impairment question is asked alongside the score, it does not contribute to the total; document the response in a separate field. If any of the 7 items are skipped, the instrument cannot be scored; partial completion is invalid and should be documented as "GAD-7 partial: 6 of 7 items completed, item 7 declined, total not calculable." Interpreting scores in inpatient or postoperative populations requires context. A patient with a fresh diagnosis, an upcoming procedure, or a new admission may experience legitimate anxiety. The 2-week recall helps prevent scoring situational anxiety as generalized anxiety disorder (GAD). Read the recall framing aloud, ensuring the score reflects the 2-week window the patient experienced before this admission, rather than the past 24 hours.

The 2007 Kroenke primary-care prevalence study extended GAD-7 beyond GAD itself. In 965 primary-care patients, the GAD-7 functioned as a useful screen for three additional anxiety-spectrum conditions at the same cutoff of 10. Social anxiety disorder: sensitivity 72%, specificity 80%. Panic disorder: sensitivity 74%, specificity 81%. PTSD: sensitivity 66%, specificity 81%. The clinical takeaway is that a positive GAD-7 in a patient who does not meet GAD criteria on follow-up interview is not a false positive in the screening sense; it is a flag pointing toward one of the other three conditions, and the clinical interview should look for them. The component-score pattern sometimes hints at the differential. A high item 7 (feeling afraid as if something awful might happen) with sub-threshold items 1 through 6 sometimes indicates panic disorder rather than GAD. A high item 6 (irritability) with arousal symptoms (items 4 and 5) in a patient with a known trauma history sometimes points toward PTSD. These are pattern hints, not diagnostic rules; the clinical interview is what establishes the diagnosis.

GAD-2, GAD-7, PHQ-9: How the Screens Layer in Primary Care

In real primary-care workflows, outpatient practices and many inpatient admission processes rarely start with the GAD-7. Instead, they use the GAD-2, which includes the first two items of the GAD-7 (anxious arousal and uncontrolled worry), as the entry-level screen. A GAD-2 score of 3 or higher prompts escalation to the full GAD-7. While sensitivity is comparable between the two, the GAD-7 has substantially higher specificity. This difference explains why clinicians escalate after a positive GAD-2 rather than treating it as the final answer. The PHQ-9 often accompanies the GAD-7 because depression and anxiety frequently coexist. In 2009, Kroenke and colleagues developed the PHQ-4, an ultra-brief 4-item screen that combines the PHQ-2 and the GAD-2 into a single instrument, detecting either condition through two screening dimensions. Administering the GAD-7 without the PHQ-9 in a patient with mood symptoms risks missing comorbid depression. Always pair it with the PHQ-9 ([see the PHQ-9 documentation guide](/guides/phq-9-documentation)) when patients endorse low mood, anhedonia, sleep changes, or appetite changes. Together, these two screens address the most common presentations of mood and anxiety in primary care.

GAD-7 Documentation in NurseChartingPro

NurseChartingPro captures anxiety-related observations in the Mental and Emotional Status category of psychiatric charting, which includes depression and broader mood symptoms. The structured GAD-7 field, featuring the seven component scores, total, severity band, and functional-impairment response, is on the Phase 5 roadmap. Once implemented, it will join the Mental and Emotional Status category. Until the structured field is available, document the score in the Notes field using the chart-entry pattern outlined later in this guide: total, seven component scores, functional-impairment response, severity band, and plan. When the structured field arrives, this documentation habit will transfer smoothly since the same elements that create a defensible Notes-field entry today will also populate the structured field tomorrow.

Common Mistakes

Charting Only the Total Without the Component Scores

Weak: GAD-7 total 16 (severe).

Strong: GAD-7 total 16 (severe). Component scores 1: 3, 2: 3, 3: 2, 4: 3, 5: 1, 6: 1, 7: 3 (each 0-3, recall 2 weeks). Functional impairment "very difficult." Score consistent with significant anxiety symptoms across the GAD spectrum; clinical interview pending. Provider notified at 1015 for evaluation.

GAD-7 without the 7 component scores hides the differential. Item-pattern shifts (high item 7 alone, or high items 4-5-6 together) point toward different conditions in the GAD spectrum. The next clinician needs the component breakdown to interpret the screen.

Treating GAD-7 as a Diagnosis

Weak: Patient has generalized anxiety disorder. GAD-7 score is 14.

Strong: GAD-7 score 14, moderate range. Score consistent with possible generalized anxiety disorder; clinical interview pending. Provider notified for diagnostic evaluation.

GAD-7 serves as a screening tool, not a definitive diagnosis. A score in the moderate or severe range suggests possible GAD (or social anxiety disorder, panic disorder, or PTSD per Kroenke 2007) but does not confirm the diagnosis without a clinical interview. Documenting "patient has GAD" based solely on a GAD-7 score constitutes an overreach in documentation.

Missing the Functional Impairment Item

Weak: GAD-7 total 11 (moderate).

Strong: GAD-7 total 11 (moderate); functional impairment "very difficult." Patient reports inability to complete daily tasks at home for the past 2 weeks.

Documenting the functional impairment question is essential for completeness, even though it does not contribute to the score. Two patients with the same total can experience very different functional impacts; the impairment response distinguishes their situations in the chart.

Scoring a Partial GAD-7 as if It Were Complete

Weak: GAD-7 total 8 (mild); patient declined item 7.

Strong: GAD-7 partial: 6 of 7 items completed, item 7 declined, total not calculable. Items 1-6 sum to 8. Patient declined to answer item 7 ("feeling afraid as if something awful might happen"); decline documented during the clinical interview.

GAD-7 cannot be scored if any item is skipped. A partial GAD-7 should be documented as such, not summed and labeled with a severity band. The decline itself is sometimes a clinical signal worth following up on.

Not Pairing With PHQ-9 in Patients With Mood Symptoms

Weak: GAD-7 score 13, moderate. The patient also reports low mood.

Strong: GAD-7 score 13, moderate. The patient also reports low mood, anhedonia, and 2 weeks of sleep disturbance; PHQ-9 administered, total 16, moderately severe, item 9 negative. Documented comorbid depression and anxiety symptoms; provider notified.

Depression and anxiety frequently co-occur, prompting Kroenke and colleagues to develop the PHQ-4 to identify both with one brief instrument. When mood symptoms accompany anxiety symptoms, GAD-7 alone fails to address the depression aspect; pairing it with PHQ-9 captures both.

Using Adult GAD-7 on a Pediatric Patient

Weak: Patient is 14. GAD-7 administered, score 11, moderate.

Strong: Patient is 14. Adolescent anxiety screen completed using SCARED (Screen for Child Anxiety Related Emotional Disorders); adult GAD-7 not used because patient is under 18 and the GAD-7 is validated for adults only.

The GAD-7 is validated for individuals aged 18 and older. Pediatric anxiety screening requires different instruments, such as SCARED, MASC, and the Spence Children's Anxiety Scale, because adolescent anxiety symptoms differ from adult presentations. Administering the adult GAD-7 to a minor results in a score that may not align with the validated cutoffs for that population.

Mrs. GarciaAge 27 — Med-surg admission for chest pain rule-out, ACS workup negative on initial troponin and ECG, no documented psychiatric history

fictional patient

Scenario

As the day-shift med-surg nurse, you care for Mrs. Garcia, a fictional 27-year-old admitted overnight for chest pain that resolved in the ED. The unit's admission protocol includes a GAD-7 for every patient and a PHQ-9 if any mood symptoms are endorsed. You complete the GAD-7 with the patient at 0930, and the score returns 16, with all 7 items scoring 2 or 3. The patient is alert, oriented, hemodynamically stable, and denies current chest pain. Cardiology follows for serial troponins and a planned outpatient stress test. The on-call hospitalist is in rounds.

Chart Entry

0930 GAD-7 Screening:

GAD-7 total: 16 (severe severity band).

Component scores (each 0-3, recall 2 weeks):
- Item 1 (nervous, anxious, on edge): 3 (nearly every day)
- Item 2 (cannot stop or control worrying): 3 (nearly every day)
- Item 3 (worrying too much about different things): 2 (more than half the days)
- Item 4 (trouble relaxing): 3 (nearly every day)
- Item 5 (restless, hard to sit still): 2 (more than half the days)
- Item 6 (easily annoyed or irritable): 2 (more than half the days)
- Item 7 (feeling afraid as if something awful might happen): 1 (several days)

Functional impairment: "Very difficult" to do work, take care of things at home, or get along with other people.

Mood symptoms reported alongside anxiety:
Patient endorsed low mood, decreased interest in usual activities, and trouble falling asleep over the past 2 weeks. PHQ-9 administered, total 11 (moderate), item 9 negative ("not at all"), functional impairment "somewhat difficult." Both screens documented as separate entries.

Action taken:
- Provider (hospitalist) notified at 0945 with GAD-7 score, severity band, item-pattern (items 1, 2, 4 all at 3 nearly every day; item 7 only "several days"), and the parallel PHQ-9 result.
- Behavioral-health consult ordered; expected within 24 hours.
- Cardiology team made aware that severe anxiety symptoms predate the chest pain admission per patient report (recall 2 weeks); workup continues.
- Patient education: outpatient mental-health resources reviewed for discharge packet, including primary-care follow-up for sustained symptom management.
- Reassess GAD-7 score is not indicated on this admission unless symptoms shift; PHQ-9 item 9 reassessment at every shift handoff per institutional policy on positive depression screens.

Annotations

Total + 7 component scores broken out:: The total alone hides the item-level pattern. Items 1, 2, and 4 all at 3 (nearly every day) with item 7 only at 1 (several days) is consistent with GAD rather than panic disorder. Listing all 7 components makes the differential visible to the next reader.
Paired with PHQ-9:: Mood symptoms were endorsed alongside anxiety, so PHQ-9 was administered the same hour. Charting both screens with both totals captures the comorbidity that GAD-7 alone would miss.
Functional impairment captured:: The "very difficult" functional impairment alongside the severe-band total communicates more clinical impact than the score alone. Required even though it does not contribute to the total.
2-week recall framing referenced:: The chart entry notes that the symptoms predate the admission per the 2-week recall window. This protects against scoring situational anxiety from the chest-pain workup as severe GAD.
Reassessment cadence specified:: GAD-7 is not routinely reassessed in inpatient short stays unless symptoms shift; PHQ-9 item 9 reassessment is the more clinically pressing repeat assessment and is documented separately.

Pro Tips

Read the Items Verbatim: GAD-7 items use plain language for a reason: validated cutoffs rely on patients interpreting the items as written. Paraphrasing item 4 as "do you feel anxious" instead of reading "trouble relaxing" often leads to different responses. Read the seven items word-for-word. The same applies to the response options: "several days" differs from "a few times" or "occasionally," and the score depends on patients mapping their experiences to the validated phrasing.
The 2-Week Recall Is Load-Bearing in Inpatient Populations: Hospitalized patients are usually anxious about something acute (the workup, the procedure, the diagnosis). The 2-week recall framing is what separates trait anxiety from state anxiety on this admission. Read it aloud: "Over the past 2 weeks, how often have you been bothered by the following problems?" Patients answering for "right now" or "the past day" produce a score that does not map to the validated cutoffs and may overestimate baseline anxiety severity.
Pair With PHQ-9 When Mood Symptoms Are Endorsed: Depression and anxiety frequently co-occur, prompting Kroenke and colleagues to develop the PHQ-4 in 2009. This 4-item screen effectively identifies both conditions. If the patient reports low mood, anhedonia, sleep changes, or appetite changes during GAD-7 administration or follow-up, add the PHQ-9 for the next assessment. Documenting both screens in the same encounter captures the comorbidity that either screen alone might miss.
Watch the Item-Pattern, Not Just the Total: The GAD-7 also identifies social anxiety disorder, panic disorder, and PTSD, according to Kroenke 2007. A high score on item 7 (feeling afraid as if something awful might happen) alongside sub-threshold scores on items 1 through 6 may indicate panic disorder rather than GAD. Similarly, a high score on item 6 (irritability) with arousal symptoms in a patient with a known trauma history may suggest PTSD. These patterns serve as clues for the clinical interview, not strict diagnostic rules. Document any notable patterns to ensure the consult clinician recognizes what you observed.
Differentiate Score from Diagnosis in Every Chart Entry: Chart "GAD-7 score 14, moderate band, score consistent with possible generalized anxiety disorder; clinical interview pending." Do not chart "patient has anxiety disorder." The score does not establish the diagnosis; the clinical interview that follows does. Keeping that distinction in your chart entry protects the next provider from having to walk back an overreach.

Chart smarter with Nurse Charting Pro

Structured assessments, AI-generated narratives, and HIPAA-compliant crypto-shredding — built for nurses who care about documentation quality.

App Store Google Play